V. Ngai

发表

One-Year Entecavir or Lamivudine Therapy Results in Reduction of Hepatitis B Virus Intrahepatic Covalently Closed Circular DNA Levels

M. Yuen, J. Fung, Ching-lung Lai, 2005, Antiviral therapy.

A Randomized Placebo-Controlled, Dose-Finding Study of Oral Lb80380 in Hbeag-Positive Patients with Chronic Hepatitis B

M. Yuen, J. Yuen, Ching-lung Lai, 2006, Antiviral therapy.

Characterization of Actinobacillus actinomycetemcomitans isolated from young Chinese aggressive periodontitis patients.

W. K. Leung, B. Cheung, E. Corbet, 2005, Journal of periodontal research.

Long-Term Lamivudine Therapy Reduces the Risk of Long-Term Complications of Chronic Hepatitis B Infection even in Patients without Advanced Disease

M. Yuen, D. Wong, J. Fung, 2007, Antiviral therapy.

Pharmacokinetics of LB80331 and LB80317 following Oral Administration of LB80380, a New Antiviral Agent for Chronic Hepatitis B (CHB), in Healthy Adult Subjects, CHB Patients, and Mice

M. Yuen, V. Ngai, John Kim, 2009, Antimicrobial Agents and Chemotherapy.

Reduction of covalently closed circular DNA with long-term nucleos(t)ide analogue treatment in chronic hepatitis B.

M. Yuen, D. Wong, J. Fung, 2017, Journal of hepatology.

M. Yuen, D. Wong, J. Yuen, 1998, The Craft of Poetry.